Search

everythinglearnresearchcommunity

for

Search:↓

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

A woman with severe angioedema improved significantly after treatment with rituximab.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

COVID-19 vaccination may trigger lupus in some people.

Lupus can progress to a more serious form, so careful monitoring is crucial.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

COVID-19 may trigger systemic lupus erythematosus in some people.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.